Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $1.5 million.

  • Lifecore Biomedical, Inc. \De\'s Prepaid Assets rose 104.24% to $1.5 million in Q2 2025 from the same period last year, while for May 2025 it was $1.5 million, marking a year-over-year increase of 104.24%. This contributed to the annual value of $1.5 million for FY2025, which is 104.24% up from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Prepaid Assets stood at $1.5 million for Q2 2025, which was up 104.24% from $2.5 million recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s Prepaid Assets' 5-year high stood at $5.9 million during Q1 2021, with a 5-year trough of $1.3 million in Q3 2021.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Prepaid Assets had a median value of $1.9 million in 2023 and averaged $2.4 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first crashed by 9049.81% in 2021, then soared by 19531.72% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Prepaid Assets (Quarter) stood at $1.4 million in 2021, then rose by 16.1% to $1.7 million in 2022, then grew by 10.28% to $1.8 million in 2023, then soared by 56.42% to $2.9 million in 2024, then crashed by 49.62% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q2 2025, $2.5 million for Q1 2025, and $2.9 million during Q4 2024.